Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results?
The management of end-stage heart failure in cardiac amyloidosis due to both light chain (AL-CA) and transthyretin (ATTR-CA) with heart transplantation has historically been limited by concerns about systemic progression after transplant. As a result, heart transplantation as a strategy was often restrictive and many p...